Amura Therapeutics Limited
Records under this name other than patents Amura Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Amura Therapeutics Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,425,562 | Inhibitors of cruzipain and other cysteine proteases Formerly held Lapsed on the fee record Ended Sep 16, 2020 · USPTO record | Lapsed on the fee record | Ended Sep 16, 2020 | USPTO record |
| US 8,053,437 | Furo[3. 2-B] pyrrol derivatives Lapsed on the fee record Ended Nov 8, 2019 · USPTO record | Lapsed on the fee record | Ended Nov 8, 2019 | USPTO record |
| US 8,039,641 | Tetrahydrofuro[3,2-b] pyrrol-3-one intermediates Formerly held Lapsed on the fee record Ended Oct 18, 2019 · USPTO record | Lapsed on the fee record | Ended Oct 18, 2019 | USPTO record |
| US 8,008,290 | Compounds Formerly held Lapsed on the fee record Ended Aug 30, 2019 · USPTO record | Lapsed on the fee record | Ended Aug 30, 2019 | USPTO record |
| US 9,045,492 | Piperazine compounds Formerly held Lapsed on the fee record Ended Jun 2, 2019 · USPTO record | Lapsed on the fee record | Ended Jun 2, 2019 | USPTO record |
| US 8,933,109 | Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitors Lapsed on the fee record Ended Jan 13, 2019 · USPTO record | Lapsed on the fee record | Ended Jan 13, 2019 | USPTO record |
| US 7,132,449 | Inhibitors of cruzipain and other cysteine proteases Lapsed on the fee record Ended Nov 7, 2018 · USPTO record | Lapsed on the fee record | Ended Nov 7, 2018 | USPTO record |
| US 8,877,927 | Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl proteinase inhibitors Formerly held Lapsed on the fee record Ended Nov 4, 2018 · USPTO record | Lapsed on the fee record | Ended Nov 4, 2018 | USPTO record |
| US 7,803,803 | Tetrahydrofuro[3,2-B] pyrrol-3-ones as cathepsin K inhibitors Lapsed on the fee record Ended Sep 28, 2018 · USPTO record | Lapsed on the fee record | Ended Sep 28, 2018 | USPTO record |
| US 7,799,791 | Tetrahydrofuro(3,2-B) pyrrol-3-one derivatives as inhibitors of cysteine proteinases Lapsed on the fee record Ended Sep 21, 2018 · USPTO record | Lapsed on the fee record | Ended Sep 21, 2018 | USPTO record |